What’s more, only about one in eight is aware that some of the
cancers can be linked to human papillomavirus, or HPV. The sexually
transmitted infection is better known for causing cervical cancer in
women, but is also behind an increase in the rate of throat cancer,
particularly among men.
“Public awareness of head and neck cancer is really, really low, and
that is probably harming people because they’re not aware of the
risk factors and symptoms,” senior author Dr. Benjamin Judson, from
the Yale University School of Medicine in New Haven, Connecticut
told Reuters Health.
Head and neck cancers include cancer of the throat, voice box, mouth
and tongue. Smoking causes more than 75 percent of the cases in the
United States, the authors write in JAMA Otolaryngology–Head and
Neck Surgery.
The cancers have been declining overall, the researchers note. But
studies show that rates of throat cancer tied to HPV, which can be
transmitted through oral sex, tripled between 1988 and 2004.
“It’s an epidemic,” Judson said.
Head and neck cancers account for about three percent of all cancers
in U.S. adults.
Head and neck cancer patients, including actor Michael Douglas, who
was diagnosed in 2010 with late-stage throat cancer that he
attributed to oral sex, tend to seek care after the disease has
progressed to advanced stages. In those cases, treatment is more
challenging and survival less likely.
“Head and neck cancer is about as common as thyroid cancer and
melanoma, but it causes more deaths than the two cancers combined,”
Judson said. “If people are aware of the risks and the signs and
symptoms, they could be diagnosed earlier.”
He and his colleagues surveyed 2,126 adults to gauge their knowledge
of head and neck cancers. The vast majority who completed an online
questionnaire knew little or nothing about the tumors or their
causes and symptoms, the study found.
Less than one percent of respondents identified HPV as a risk factor
for mouth and throat cancer, though in specific questions about 13
percent said they knew of an association between HPV and throat
cancer.
Respondents with a college degree were more likely to associate HPV
infection with throat cancer; still, less than 15 percent made the
connection.
Less than 15 percent of respondents recognized sores that never heal
as a symptom of the diseases. Only five percent recognized a sore
throat as a symptom and just half a percent saw mouth or throat
bleeding as a sign of cancer.
The most common symptoms of throat cancer are voice changes,
difficulty swallowing, mouth lesions that don’t heal, neck lumps and
mouth sores, speech pathologist Edie Hapner told Reuters Health.
[to top of second column] |
Hapner, from Emory University in Atlanta, was not involved in the
current research but has studied public awareness of head and neck
cancers.
The lack of public knowledge about the diseases came as no surprise
to Hapner.
“The biggest problem is not just the lack of knowledge by the public
but by a lot of the medical community,” she said.
In a not-yet-published study, Hapner questioned medical students who
had already received training in head and neck cancers and found
they felt insufficiently prepared to perform screening exams for
head and neck tumors. An hour and a half of training significantly
improved the medical students’ confidence and ability, she said.
In a 2013 recommendation, the government-backed U.S. Preventive
Services Task Force said there is not enough evidence to determine
whether screening people without symptoms for oral cancer has any
net benefit.
The annual number of HPV-positive throat cancers is expected to
surpass the annual number of cervical cancers by the year 2020,
according to a 2011 study in the Journal of Clinical Oncology.
Researchers in 2012 estimated that nearly seven percent of Americans
ages 14 to 69 had oral HPV infections. Moreover, HPV rates were as
high as 20 percent among people who had more than 20 lifetime sex
partners or smoked more than a pack of cigarettes per day.
Two vaccines that reduce the risk of HPV infection and were designed
to prevent cervical cancer are available for children and young
adults. But researchers do not know if they prevent oral HPV
infections, and federal regulators have not approved either vaccine
for the prevention of head and neck cancer.
“Unfortunately, we’re going to see more and more people with head
and neck cancer,” Judson said. “There’s a need for more public
education to raise awareness.”
SOURCE: http://bit.ly/1p2B0GJ JAMA Otolaryngology-Head and Neck
Surgery, online June 5, 2014.
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |